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Although terrorist bombings have tormented the world for a long time, currently they have reached
unprecedented levels and become a continuous threat without borders, race or age. Almost all of them are caused
by improvised explosive devices. The unpredictability of the terrorist bombings, leading to simultaneous generation
of a large number of casualties and severe “multidimensional” blast trauma require a constant vigilance and
preparedness of every hospital worldwide. Approximately 1-2.6% of all trauma patients and 7% of the combat
casualties require a massive blood transfusion. Coagulopathy is presented in 65% of them with mortality exceeding
50%. Damage control resuscitation is a novel approach, developed in the military practice for treatment of this
subgroup of trauma patients. The comparison with the conventional approach revealed mortality reduction with
40-74%, lower frequency of abdominal compartment syndrome (8% vs. 16%), sepsis (9% vs. 20%), multiorgan failure
(16% vs. 37%) and a significant reduction of resuscitation volumes, both crystalloids and blood products. DCS and
DCR are promising new approaches, contributing for the mortality reduction among the most severely wounded
patients. Despite the lack of consensus about the optimal ratio of the blood products and the possible influence
of the survival bias, we think that DCR carries survival benefit and recommend it in trauma patients with
exsanguinating bleeding.
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Although terrorist bombings have tormented the world
for a long time, currently they have reached unprece-
dented levels and become a continuous threat without
borders, race or age. Between 1973 and 1983, 5 075
bombing attacks with 3 689 deaths and 7 991 injuries
were recorded worldwide [1]. In USA, only for 1990,
there were 1 582 bombings with 222 injuries and 27
deaths, whereas for the period 1990–95 there were 15
700 incidents with 3 176 injuries and 355 deaths [2].
The peak is the notorious collapse of the World Trade
Center (2001) caused 2 819 deaths, the train bombings
in Madrid (2004) led to 191 deaths and 2000 injured and
the attacks in London (2005) with 56 deaths and over
700 injured. In Israel, for the period 2000–2002 there
were 1 116 terror-related events [3].* Correspondence: gerasimpopivanov@rocketmail.com
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article, unless otherwise stated.Characteristic of the modern blast trauma
Approximately 64% of the combat injuries and most of
the civilian ones are caused by improvised explosive de-
vices (IEDs) [4]. In contrast to the military setting, the
civilian bombings generate a higher dead/wounded ratio,
5–22 vs. 1:2–1:5 [5]. The blast trauma has unique,
“multidimensional” injury pattern due to the simultan-
eous action of four injury mechanisms [6].
Primary blast injuries (55%) are result from the blast
wave and affect the air-containing organs (lung, tym-
panic membrane, bowels). Usually, blast lung is mani-
fested 24–48 after the blast and was found in 47% of the
cases with immediate death, accounted for 11% mortality
among the survivors [7]. Blast bowel injuries occur in
only 1.2%.
Secondary blast injuries (60-70%) are caused by the
secondary fragments (SFs) produced by the blast. SFs in-
juries are multiple and require a special awareness dur-
ing the initial evaluation for several reasons [8,9]. The
multiple superficial wound can cause exsanguinating
bleeding along with the possibility for multiple bodyntral Ltd. This is an Open Access article distributed under the terms of the
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juries of the viscera require meticulous exploration of
the entire abdominal cavity during the laparotomy. Add-
itionally, there is a risk for transmission of infections
such as AIDS and hepatitis [10].
Tertiary blast injuries (27-35%) are result from the
body displacement by the blast wind and the structural
collapse of the buildings. They lead to different kinds of
blunt trauma – acceleration-deceleration injuries (usu-
ally of solid organs), fractures, traumatic amputations
and head trauma. Severe brain injuries account for 71%
of the immediate and 52% of the late fatalities [Fryc88].
Quaternary blast injuries constitute about 10% of all
injuries and include burns, commonly associated with
inhalation injuries and chemical poisoning [11].
In a comprehensive analysis comparing 906 blast vic-
tims and 55 033 patients with conventional traumas,
Kluger et al., found that blast is associated with severer
trauma (ISS > 16 in 28.7% vs. 10%), with multiple body re-
gions involvement (>3, 28.3% vs. 6.2%), and higher pro-
portion of those requiring different kind of surgery (50.8%
vs. 36.6%) [12]. Blast victims (BVs) suffered more fre-
quently from internal injuries (32% vs. 23%), open wounds
(59% vs. 17%), burns (17% vs. 5%), nerves and blood ves-
sels injuries (8% vs. 1% and 4% vs. 1%, respectively), and
higher requirements for blood and blood products (5.4%
vs. 1.4%) [13]. BVs required more frequent intubation
(12.2% vs. 1.9%), chest decompression (5.9% vs. 1.3%), ED
thoracotomy (1.2% vs. 0.2%) and angiographies (2.9% vs.
0.4%) at the admission. Blast victims were more frequently
in ICU (26% vs. 7%), with higher mortality rates (6.1% vs.
2%) and rehabilitation needs (12.9% vs. 8.2%) [12].
Approximately 1–2.6% of all trauma patients and 7%
of the combat casualties require a massive blood transfu-
sion (MT) [14,15]. Coagulopathy is presented in 65% of
them with mortality exceeding 50% [14]. The risk factors
for MT are systolic blood pressure < 110 mmHg, pulse >
105, hematocrit < 32, pH 7.25. In the presence of 3 or 4
of them, the risk is 70% and 85%, respectively [14]. Ac-
cording to Moore, the combination of ISS > 25, pH <
7.10, mean arterial pressure < 70 mmHg and T < 34°
leads to coagulopathy in 98% of the cases [16].
Analysis of 82 cases, died in Iraq in Special Forces Op-
erations, revealed that 12 of them (15%) were potentially
survivable. 8/12 (66.7%) or 9.8% of all (8/82) were due to
truncal hemorrhage with potential benefit from damage
control resuscitation (DCR) [17].
Damage control surgery (DCS) and damage control re-
suscitation (DCR) were developed in the last 3 decades
with aim to diminish mortality within subgroup of the
patients with exsanguinating bleeding, thought as unsal-
vageable with the conventional approach. They are im-
plicitly interrelated and in fact DCS can be considered
as a part of DCR.Damage control surgery (DCS)
In 1983, Stone and al., first reported a series of 17 pa-
tients treated by a rapid control of the bleeding, open
abdomen and definitive operation after physiologic
stabilization. Twelve of them survived (70.9%) versus
1/12 (8.3%) treated conventionally [18]. The term “dam-
age control” was introduced in 1993 by Rotondo and al.
[19]. Subsequent studies reported 33%-89% reduction of
the mortality rates [20-22]. A cumulative analysis of 1
001 damage control laparotomies revealed overall mor-
tality 50% and morbidity rate of 40% [23].
The aim of DCS is to stop the so-called lethal
triad – hypothermia (Т < 35°), acidosis (pH < 7.2, lactate
level >2.5 mmol/l) and coagulopathy (INR > 1.6, аPTT >
60 sec.) [16]. The indications for DCS are exsanguinating
bleeding with early onset coagulopathy, inaccessible great
venous injuries (retrohepatic vena cava, pelvic veins),
presence of extra-abdominal life-threatening injuries, in-
ability for definitive repair due to mass casualty influx,
lack of qualification or equipment, a need for time-
consuming procedures (>90 min.) on the background of
persisting hemodynamic instability [24-26]. It consists of
four steps.
Ground 0 includes early recognition of the need for
DCS, aggressive warming and resuscitation with blood
products with subsequent rapid transfer to the operating
theater [27]. The second step is a rapid control of
hemorrhage and contamination (“resuscitative surgery”).
Control of the contamination is best performed through
a bowel stapler resection, simple suture/ligation or only
clamping of the injured bowel segment. Hemorrhage
control includes splenectomy, nephrectomy, temporary
shunts or abdominal package. This stage should be lim-
ited to 1 hour and as a rule the abdomen is left opened.
V.A.C. Abdominal Dressing System is an excellent method
for temporary abdominal coverage. It provides good
splinting of the abdominal wall, prevention of adhesions
and lateral retraction of the fascia, which reflects in higher
rate of primary facial closure, diminished risk for ACS and
enteroathmospheric fistulas [28-30]. The next steps are
damage control resuscitation, followed by definitive repair
of the injuries after restoration of the normal physiology.
Damage control resuscitation (DCR)
The aim of DCR is minimizing of the blood loss, im-
provement of the tissue oxygenation, normalization of
physiology and preparation for the next stage of defini-
tive repair of the injuries [31,32]. The importance of this
step is well-illustrated by the thought of the great sur-
geon lord Moynihan: “The modern operation is safe for
the patient. The modern surgeon must make the patient
safe for the modern operation.”
Traumatic coagulopathy (TC) occurs early after the
trauma and is presented at the patient admission [33,34].
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age, hypoxia and ischemia, which lead to release of pro-
inflammatory cytokines, cateholamines, an activation of
complement and coagulation cascade with subsequent
consumption coagulopathy and hyperfibrinolysis [33,34].
On other hand, hypothermia, acidosis and hemodilution
in the cases with severe trauma are significant contribut-
ing factors. The combination of ISS > 25, pH < 7.10,
MAP < 70 mmHg and Т < 34° leads to TC in 98% of the
cases [16,35]. Characteristic features of TC are hyperfi-
brinolysis, activation of tissue-type plasminogen activa-
tor (tPA), lack of microtrombi, thrombomodulin-protein
C activation and decreased levels of protein C and anti-
thrombin III [34,36-38].
The failure of the standard resuscitation is attributed
to massive crystalloid administration, which leads to he-
modilution and reperfusion injuries, worsening the tis-
sue perfusion, acidosis, coagulopathy and systematic
inflammatory response. These events reflect in a higher
frequency of ACS and multiple organ failure (MOF)
[39-41].
DCR includes three major components: (1) permissive
hypotension – keeping a blood pressure at 90 mmHg or
palpable pulse in a conscious patient until definitive con-
trol of the bleeding [14,41-44], (2) minimal use of crys-
talloids, and (3) a rapid administration of blood
products (PRBC, FFP, platelets) in ratio 1:1:1 in the mili-
tary practice (translated in 6 units PRBC, 6 units FFP
and 1 unit apheresis platelets) [36,45-50]. TEG/ROTEM
is recommended as a rapid test for investigation of the
coagulation status [51].
The administration of recombinant FVII is controver-
sial. Although it is recommended by JTTS and European
consensus, in a randomized control trial, Hauser et al.
found reduced blood products use, but no survival bene-
fit [51,52].
Fibrinogen concentrate or cryoprecipitate are associ-
ated with improved survival should be administrated
when plasma fibrinogen level is less than 1 g/l at an ini-
tial dose of 3-4 g or 50 mg/kg, respectively or in cryo-
precipitate:PRBC ratio 1:1 [51,53].
Tranexamic acid (TEA) is a competitive inhibitor of
plasmin and plasminogen and is considered in the pa-
tients with trauma coagulopathy due to the recognition
of the early activation of the hyperfibrinolysis [33,34]. A
retrospective military study (MATTERs) showed signifi-
cantly lower mortality within the TEA group than no-
TEA group (17.4% vs. 23.9%), which was more pro-
nounced in the group of the patients with MT (14.4% vs.
28.1%, OR 7.22) [54]. The randomized placebo-
controlled trial Crash-2, including 20 211 trauma pa-
tients, found significant reduced mortality in patients
with massive bleeding (OR 0.85) after administration of
TEA. However, this effect was evident when TEA wasgiven within the first 1 hour (RR 0.68) and 1–3 hours
(RR 0.79) after the trauma event. Importantly, the treat-
ment given after 3 h was associated with increased risk
for bleeding and death (RR 1.44, p < 0.05 [55]. On other
hand, this beneficial effect may be attributed to the large
sample size. Additionally, no significant differences in
transfusion requirements between the two groups were
recorded. TEA should be given as early as possible after
trauma in all patients requiring MT. TEG/ROTEM is
recommended for monitoring of the fibrinolysis and to
direct the treatment [35].
There is no consensus about the optimal ratio FFP:
RPBC. Most authors demonstrated that ratios greater
than 1:2 were associated with reduced mortality
[35,43,46,47,50]. In univariate analysis, Duchesne et al.,
found significantly reduced mortality rate (1:1 vs. 1:4, 26%
vs. 87.5%) among the patients received >10 units of PRBC,
whereas the multivariate analysis revealed relative risk for
mortality of 18.9 in ratio 1:4 [47]. In a more recent study,
the same author found improved 30-day survival in a
greater ratio (73.6% vs. 54.8%, 1:1.2 vs. 1:4.2) [56].
The reported decrease of the mortality rates varies be-
tween 19% vs. 65% (1 vs. 1:1.4) [57], 20% vs. 31% (1:1.3
vs. 1:1.6) [50], 40% vs. 60% (>1:2 vs. <1:2) [58]. Cotton
et al., revealed a striking reduction of mortality rate with
74% [59] and also a lower frequency of ACS (8% vs.
16%), sepsis (9% vs. 20%) and MOFS (16% vs. 37%) in
comparison to the conventional approach [42]. In other
study, the same author reported a significant reduction
of resuscitation volumes, both crystalloids and blood
products, and improved 24-hour and 30-day survival of
the patients received DCR [60].
Despite the optimistic results, several problems should
be additionally discussed. First of all, the frequency of
ARDS and multiorgan failure (MOF) after MT and their
effect on mortality still need to be elucidated [61]. RBC
transfusion itself is associated with increased risk for
ARDS and MOF [15,62]. Meta-analysis revealed that the
high plasma:PRBC ratios in a setting of MT were associ-
ated with increased ARDS risk (OR, 2.92). Nevertheless,
they were associated with mortality reduction (OR, 0.38)
[63]. Park et al., also found a higher frequency of ARDS
in MT (8.45 vs. 5.3%), but without significant difference
in the mortality (17.4% vs.16.3%) among the combat cas-
ualties from Iraq and Afghanistan [64].
Intriguingly, a recent, multicenter, prospective trial in
106 patients, based on TEG monitoring and serum lac-
tate measurement, showed that DCR is “neither
hemostatic, nor resuscitative” [65].
It should be mentioned that the reported lower mor-
tality rates in higher ratios may be a result of so-called
survival bias (SB). Due to the common practice RPBC to
be administered firstly and as most deaths occurred in
the first hours after the trauma, it has been suggested
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more blood product and to achieve higher FFP:PRBC ra-
tio [66]. However, Ho et al., showed that from 21 stud-
ies, showing a survival benefit, 11 were SB-prone and 10
SB-unlikely. Five SB-unlikely studies showed no benefit
in high ratios [67]. Two recent studies addressed SB and
found that the improved survival is not influenced by
SB. A multicenter prospective study found that high
FFP:PRBC and platelets:PRBC ratios were associated
with improved survival as early as 6 hours and through-
out the first 24 hours [68]. Similarly, the Prospective,
Observational, Multicenter, Major Trauma Transfusion
(PROMMTT) study, including 905 patients from 10
Trauma centers, found decreased 6-hour mortality in
high FFP:PRBC (HR, 0.31) [69].
At last, but not least, the definition of MT protocol
varies between different Institutions and usually includes
over 10 U PRBC/24 hours [35,45]. Kashuk et al., pro-
posed this definition to be changed to 10 U per 6 hours
[70]. To avoid the possible selection bias, Savage et al.,
propose a new definition, which includes >3 U PRBC for
1 hour within the first 24 hours after the trauma [71].
The authors found that this critical administration
threshold (CAT) had a stronger association with mortal-
ity vs MP. (RR, 3.58 vs. 1.82). CAT identified 75% of the
deaths, while MT identified only 33%.
The need for randomized controlled trials and multi-
center collaboration due to the relatively small number
of patients requiring DCR in a civilian setting is obvious
[14]. We are waiting with interest the results from the
recent randomized trial PROPPR, which includes 608
patients and compares the effectiveness of 2:1:1 and
1:1:1 ratios [72].
Conclusion
The unpredictability of the terrorist bombings, leading
to simultaneous generation of a large number of casual-
ties and severe “multidimensional” blast trauma require
a constant vigilance and preparedness of every hospital
worldwide.
DCS and DCR are promising new approaches, contrib-
uting for the mortality reduction among the most se-
verely wounded patients. Despite the lack of consensus
about the optimal ratio of the blood products and the
possible influence of the survival bias, we think that
DCR carries survival benefit and recommend it in
trauma patients with exsanguinating bleeding.
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